Bone-only Metastatic Castration-Resistant Prostate Cancer (CRPC)
1 clinical trials · Condition
◉ Watch Bone-only Metastatic Castration-Resistant Prostate Cancer (CRPC)
| Record | Firm | Date |
|---|---|---|
| A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer (NCT02396368) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-03-01 |
Track Bone-only Metastatic Castration-Resistant Prostate Cancer (CRPC) automatically
Every clearance here is in the API, with alerts when new ones post.